Compelling evidences from transgenic mice, immunoprecipitation data, gene expression analysis, and functional heterologous expression studies supported the role of Kv channel interacting proteins (KChIPs) as modulators of Kv4 (Shal) channels underlying the cardiac transient outward current and neuronal A-type current. Till now, there are four members (KChIP1 -4) identified in this family. KChIP1 is expressed predominantly in brain, with relative abundance in Purkinje cells of cerebellum, the reticular thalamic nuclei, the medial habenular nuclei, the hippocampus, and striatum. Our results from in situ hybridization and immunostaining assay revealed that KChIP1 was expressed in a subpopulation of parvalbumin-positive neurons suggesting its functional relationship with the GABAergic inhibitory neurons. Moreover, results obtained from KChIP1-deficient mice showed that KChIP1 mutation did not impair survival or alter the overall brain architecture, arguing against its essential function in brain development. However, the mice bearing KChIP1 deletion showed increased susceptibility to anti-GABAergic convulsive drug pentylenetetrazole-induced seizure, indicating that KChIP1 might play pivotal roles in the GABAergic inhibitory system.
Introduction
Voltage-gated ion channels are comprised of poreforming, transmembrane a-subunits associated with one or more modulatory subunits. A family of cytoplasmic K þ channel interacting proteins known as
KChIPs was found to co-associate with transient voltage-gated potassium channels of the Kv4 (Shal) gene family. Till now, there are four members (KChIP1 -4) identified in this family [1] . Previously, it has been shown by northern blot analysis that KChIPs are predominantly expressed in brain, whereas transcripts of KChIP2 are also detected in heart [2] . Consistent with the function in modulating potassium channels, deletion of KChIP2 from mouse genome results in a complete loss of calcium-dependent transient outward potassium current and confers susceptibility to ventricular tachycardia [3] . KChIP3 (also referred as DREAM and calsenilin), a putative transcriptional repressor for the prodynorphin gene, has the ability to bind the Alzheimer's disease gene presenilin-2. Previous studies demonstrated that KChIP3-deficient mice showed both reduced responses in models of acute pain through a transcriptional mechanism and decreased b-amyloid production by down-regulating g-secretase activity [4 -6] . In spite of these findings, the function of KChIPs, especially in brain, remains unclear. KChIP1 is expressed predominantly in brain, with relative abundance in cerebellum, Purkinje cells of cerebellum, hippocampus, striatum, and the reticular thalamic and medial habenular nuclei [2] . To gain insights into the possible function of KChIP1, we investigated its sub-regional localization in the adult mouse brain and found that KChIP1 was expressed by a subpopulation of parvalbumin-positive neurons suggesting its functional relationship with the GABAergic inhibitory neurons. Furthermore, we generated the KChIP1-deficient mouse, and the mouse showed increased susceptibility to pentylenetetrazole (PTZ)-induced seizure, supporting KChIP1's potential pivotal roles in the GABAergic inhibitory system.
Materials and Methods

Mice
Mice were maintained under specific pathogen-free condition in the animal facility of Burnham Institute for Medical Research (La Jolla, CA, USA). All manifestations were undergone in strict accordance with the Guide for the Care and Use of Laboratory Animals described by the National Institutes of Health. The number of animals used was kept to a minimum, and all procedures were performed on deeply anesthetized animals to minimize suffering.
In situ hybridization cDNA encoding the first exon of KChIP1 in pBluescript was linearized using appropriate restriction enzyme and purified with a Qiaquick PCR kit (Qiagen, Hilden, Germany). Digoxigenin-labeled probes were synthesized (DIG RNA Labeling Kit, Boehringer Mannheim, IN, USA) and purified using a G50 Quick Spin column (Roche Diagnostics, IN, USA).
Mice were anesthetized by inhalation of isoflurane and fixed by transcardiac perfusion with 4% paraformaldehyde in phosphate-buffered saline (PBS). Brains were removed, further fixed at 48C overnight followed by overnight immersion in PBS containing 30% sucrose at 48C. Specimens were mounted in opti-mum cutting temperature compound and cut into serial sections 45-mm thick on a cryostat and used immediately.
Mouse brain sections were fixed in 4% paraformaldehyde for 20 min, washed twice in PBS for 5 min, and treated with 1 mg/ml proteinase K in 50 mM Tris -HCl, pH 7.5, 5 mM ethylenediamine tetraacetic acid (EDTA) for 20 min. After washing in PBS for 5 min, sections were fixed again for 15 min, treated with 0.25% acetic anhydride in 0.1 M triethanolamine for 10 min, followed by washing in PBS for 5 min. Pre-hybridization was performed in pre-hybridization buffer (50% formamide, 5Â SSC, 0.3 mg/ml yeast tRNA, 100 mg/ml heparin, 1Â Denhardt's, 0.1% Tween-20, 0.1% CHAPS, and 5 mM EDTA) for 2 h at 608C, followed by hybridization with 1 mg/ml digoxigenin-labeled probes at 608C overnight. After hybridization, sections were washed in 2Â SSC at 608C for 15 min followed by 1 mg/ml RNase at 378C for 30 min, washed twice in 0.2Â SSC at 608C for 30 min each, three times in polybutylene terephthalate (PBT) (0.1% Triton X-100, 2 mg/ml BSA) at room temperature for 20 min each.
For detection, sections were blocked in blocking buffer (5% goat serum in PBT) at room temperature for 1 h, followed by reacting with alkaline phosphatase-conjugated anti-digoxigenin Fab fragments (1:2000; Boehringer Mannheim) 48C overnight. Unbound Fab fragments were removed by washing three times for 20 min each in PBT. Sections were developed by incubating in the alkaline phosphatase buffer (100 mM Tris, pH 9.5, 50 mM MgCl 2 , 100 mM NaCl, 0.1% Tween-20) containing nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indolylphosphate substrate (NBT/BCIP) at room temperate until they were seen in appropriate color.
Immunohistochemistry studies
After in situ hybridization, sections were then permeabilized with 0.1% Triton X-100, blocked with 5% goat serum/0.1% Triton, and incubated with parvalbumin antibody (1:1000; Novus Biologicals Inc., Littleton, CO, USA) overnight at 48C followed by incubation with Cy3-labeled secondary antibody (1:500; Jackson ImmunoResearch Laboratory, West Grove, PA, USA). Images were taken under microscope.
Double-labeled immunofluorescence staining of brain sections
Free-floating sections were blocked with a 5% goat serum solution in phosphate buffer containing 0.1% Triton X-100, and incubated overnight at 48C in vehicle containing rabbit parvalbumin antibody (1:1000; Novus Biologicals Inc.) and mouse KChIP1 monoclonal antibody (1:500; Abgent, San Diego, CA, USA). Sections were washed and incubated with Cy2-or Cy5-labeled secondary antibodies (1:500; Jackson ImmunoResearch Laboratory). Images were taken under microscope.
Generation and characterization of KChIP1-deficient mice
The targeting construct was made from a 2.8 kb genomic fragment of KChIP1 isolated from the 129SVJ mouse genomic library. Out of G418-resistant embryonic stem (ES) clones, one clone was identified as homologous recombinants based on Southern blot analysis and was microinjected into J1 129SV blastocysts that were subsequently transferred to pseudopregnant females. Chimeric male mice were crossed with C57BL/6 breeders. Genotyping was performed by Southern blot analysis and the mRNA level of Pentylenetetrazole-induced seizure Twenty-two wild-type mice, 22 heterozygous mutant mice, and 26 homozygous mutant mice were used in the study. Seizure was induced in 2-3 months old mice by intraperitoneal injection of PTZ (65 mg/kg body weight; Sigma, St Louis, MO, USA) dissolved in 0.9% normal saline. Mice were monitored for seizure behavior for 1 h after injection. The initial time of seizure onset and the outcome after seizure of individual mice were recorded.
Results
KChIP1 was expressed in parvalbumin-positive neurons To determine KChIP1's distribution in brain, in situ hybridization was performed in the brain of wild-type mice. As described in our previous data [2] , KChIP1 transcripts were distributed in all regions of the brain with enrichment in cerebellum Purkinje cells, hippocampus, striatum, reticular thalamic, and medial habenular nuclei. Because parvalbumin, a gene related to GABAergic system, is also enriched in cerebellum Purkinje cells, hippocampus, and the reticular thalamic, in situ hybridization and immunohistochemistry staining were performed in these regions to investigate whether KChIP1-positive neurons were co-distributed with GABAergic neurons. As shown in Fig. 1 (Fig. 2) . Mice homozygous for the targeted KChIP1 allele were confirmed either by Southern blot analysis with a 3 0 probe [ Fig. 3(A) ] or by RT-PCR [ Fig. 3(B) ]. The KChIP1-mutant mice were born with an expected Mendelian frequency, indicating no embryonic lethality. A detailed comparison of the weight and brain structure revealed no abnormalities in the KChIP1 homozygous mutant mice. They grew into adulthood externally indistinguishable from their wild-type littermates (Fig. 4) .
KChIP1 mutant mice showed increased susceptibility to pentylenetetrazole-induced seizure
The immunostaining results revealed that KChIP1 was expressed in a subpopulation of parvalbumin-positive neurons, suggesting its functional relationship with the GABAergic inhibitory neurons. However, the KChIP1-deficient mice did not show any seizure under the normal housing. So we used PTZ to test if the threshold to the seizure had been changed. As shown in Table 1 , the total incidence of seizure (including seizure onset in 10 min group or in 2 min or dead group) in KChIP1 þ/2 (100%) and KChIP1 2/2 mice (85%) was significantly higher than in KChIP1 þ/þ mice (60%). RT-PCR analysis of mRNA from different brain regions using KChIP1-specific primers (KChIP1). A few regions were studied which were as follows: Ce, cerebellum; Cox, cortex; Hip, hippocampus; Tha, thalamus. The same mRNA was detected with primers specific to GAPDH to show equal loading. Molecular weight makers are shown on the left side. Moreover, the percentage of the immediate seizure symptom in 2 min or dead in homozygous mutant mice (69%) was higher than that in heterozygous (59%) or wild-type littermates (41%), suggesting that the sensitivity to PTZ-induced seizure were increased in KChIP1 þ/2 (P , 0.01) and KChIP1 2/2 mice (P , 0.05) compared with KChIP1 þ/þ mice.
Discussion
Our previous study showed that KChIP1 transcripts were highly expressed in the reticular thalamic nucleus and cerebellum Purkinje cells where GABAergic interneurons were located [2] , indicating its participation in modulating inhibitory neuronal function. To shed light on the potential relationship between KChIP1 and GABAergic system, in situ hybridization and immunostaining assay were performed in wild-type mice brain. Consistent with our hypothesis, there were significant KChIP1/parvalbumin double-positive neurons at these encephalic regions, giving the evidence of its functional relationship with the GABAergic inhibitory neurons.
To further elucidate the relationship between KChIP1 and GABAergic system in vivo, KChIP1-deficient mice were generated. The fact that no embryonic lethality or significant difference in brain and weight was observed in these mice compared with their wild-type littermates hinted that KChIP1 may not be requisite for embryo growth and development.
GABAergic neurons are the major inhibitory cell type in the mammalian brain. As the major inhibitory neurotransmitter in brain, gamma aminobutyric acid (GABA) inhibits post-synaptic target cells through GABA-A and GABA-B receptor-mediated increase in Cl 2 and K þ conductance, respectively [7] [8] [9] . It has been widely accepted that GABAergic mechanism is involved in the occurrence of seizure, and the inhibitory function of GABAergic is associated with the activity pattern of generalized seizures. Furthermore, some prophylactic anti-malarial drugs, such as quinine and mefloquine, have been shown to cause seizures through disturbing the status of the GABAergic system and impairing GABA transmission, while muscimol, diazepam, and phenobarbitone attenuate mefloquine seizures through GABA neurotransmission [10, 11] . Su et al. [12] found that KChIP1 was highly co-localized with GABA transmitter in hippocampus and cerebral cortex. They also found that the number of KChIP1 was significantly increased, especially in CA1 and CA3 regions of the acute PTZ-induced convulsive rats, whereas no KChIP1 expression changes were observed in the chronic PTZ-induced convulsive rats, implying the relevance of PTZ-induced epileptic activity to the up-regulation of KChIP1 expression. In this study, we found that KChIP1 positive neuron was co-localized with GABAergic neuron while no other seizure was observed in KChIP1-deficient mice under normal housing. The fact that the preferential expression of KChIP1 in GABAergic neuron and the sensitivity of KChIP1-deficient mice to PTZ-induced epilepsy seizure implied that the increased expression of KChIP1 might primarily strengthen rather than attenuate the activity of GABAergic neurons, resulting in inhibition of the pathways to motor seizure. Whether the anti-epilepsy mechanism of KChIP1 through GABAergic neuron was by facilitating GABA release of presynaptic mechanisms, by promoting the uptake of GABA from synaptic cleft, or by postsynaptic mechanisms needs further study. In the nervous system, voltage-sensitive K þ channels play a crucial role in both mediating and regulating the electrical excitability of neurons, such as the determination of the resting membrane potential, shaping of the action potential, regulation of neurotransmitter release, and neuronal firing patterns. PTZ is widely used to elicit epileptic activity by influencing the membrane-associated part of the potassium channel [13] , and in cultured neurons, PTZ results in an alteration of potassium current to a more easily burst-like activity. The binding of KChIP1 to the cytoplasmic N-terminal of Kv4, a voltage-gated K þ (Kv) channel a-subunit, dramatically evokes A-type K þ current in heterologous expression systems, which are transiently activated and inactivated rapidly. Moreover, A-type Kv4 channels play a dynamic Pentylenetetrazole (PTZ; 65 mg/kg weight) was injected to induce seizure in wild-type, heterozygous, and homozygous mutant mice. The number of mice without seizure symptom, with seizure symptom in 10 min, and with the immediate seizure symptom in 2 min or dead was calculated.
role in determining dendritic excitability [14] . Bernard et al. [15] also showed that the amplitude of backpropagating action potentials was increased in CA1 pyramidal cell dendrites in pilocarpine-induced temporal lobe epilepsy, suggesting decreased functional expression of dendritic Kv4 channels and Monaghan et al. [16] showed that Kv4.2 in CA1 stratum radiatum and Kv4.3 in the molecular layer of the dentate gyrus decreased 12 weeks post-status epilepticus compared with the control animal, and KChIP was lost in interneurons throughout the dentate gyrus 4 weeks post-status epilepticus. They also demonstrated that Kv4.2 mRNA expression was present in cerebellum, hippocampus, medial habenula, cerebral cortex, and thalamus and there was significant downregulation of Kv4.2 mRNA in dentate granule cells of hippocampus following seizure activity induced by convulsant drug pentylenetetrazole treatment through an unknown mechanism. In our study, we found that KChIP1 facilitated the traffic of Kv4 to cell membrane. Combing results from others and ours, we speculate that inhibition of seizure occurrence by KChIP may be owing to the modulation of membrane excitability resulting from the binding of KChIP to Kv4 channels.
